Chinedu Mmeje, MD
Urology · Gilbert, AZNPI 1245467489
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $89,845 of the $114,277 with a category attached, or 78.6%. Ferring Pharmaceuticals Inc. accounts for 88.1% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $70,430, more than ten times the $334 reported in 2019. Among urology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $879.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$101K
- Intuitive Surgical$8K
- Urogen Pharma, Inc.$5K
- Bayer$275
- Photocure Inc$169
- Procept Biorobotics Corporation$149
- plus $202 from 5 others
Across 21 payments — averaging $5459.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dendreon Pharmaceuticals LLC$72K
- Pfizer$43K
What the payments were for
- Speaking & faculty fees$89,84579%
- Travel & lodging$15,04013%
- Food & beverage$3,4033%
- Education$5,9885%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 89 | $100,728 |
| Intuitive Surgical | 20 | $8,024 |
| Urogen Pharma, Inc. | 6 | $4,728 |
| Bayer | 3 | $275 |
| Photocure Inc | 2 | $169 |
| Procept Biorobotics Corporation | 1 | $149 |
| Boston Scientific | 3 | $51 |
| Conmed Corporation | 1 | $50 |
| Johnson & Johnson | 3 | $49 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| Caris MPI, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADSTILADRIN$99,732
- Da Vinci Surgical System$4,569
- ZUSDURI$4,532
- DA VINCI SP$3,000
- Nubeqa$270
- Xofigo$170
- AquaBeam Robotic System$149
- JELMYTO$110
How this compares
$114,277 in reported general payments places this provider in the 95th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 86 | $1,078 |
| Oxybutynin Chloride ErOxybutynin Chloride | 36 | $659 |
| Cefdinir | 23 | $267 |
| Finasteride | 22 | $231 |
| Levofloxacin | 28 | $56 |
| Ciprofloxacin Hcl | 14 | $44 |
Paid to pharmacies, not to this prescriber.
Other urology in Gilbert
- John LinGilbert$108K
- Pratik PatelGilbert$58K
- Kian AhmadiehGilbert$19K
- Frank SimonciniGilbert$11K
- Devin PatelGilbert$11K
- Mitchell HumphreysPhoenix$358K
- Shawn BlickGoodyear$336K
- Daniel JaffeePhoenix$280K
- Rahul MehanMesa$277K
- Mitzi BarmatzTucson$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.